Milestone Pharmaceuticals Inc
MIST
Company Profile
Business description
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Contact
1111 Dr. Frederik-Phillips Boulevard
Suite 420
MontrealQCH4M 2X6
CANT: +1 514 336-0444
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
38
Stocks News & Analysis
stocks
A look into newly listed Glencore’s valuation
A new ASX heavyweight with coal, copper and trading exposure.
stocks
Meta is up 9% this year. Is it still a buy ahead of earnings?
We’ll be watching Muse agent adoption, revenue growth, and more.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,959.40 | 15.20 | 0.17% |
| CAC 40 | 7,838.49 | 29.56 | -0.38% |
| DAX 40 | 25,304.42 | 15.35 | -0.06% |
| Dow JONES (US) | 52,495.88 | 529.85 | 1.02% |
| FTSE 100 | 10,733.00 | 31.69 | -0.29% |
| HKSE | 23,867.74 | 319.09 | -1.32% |
| NASDAQ | 26,424.82 | 6.07 | -0.02% |
| Nikkei 225 | 64,075.42 | 841.28 | -1.30% |
| NZX 50 Index | 13,608.13 | 23.56 | -0.17% |
| S&P 500 | 7,712.57 | 21.84 | 0.28% |
| S&P/ASX 200 | 8,834.10 | 17.20 | 0.20% |
| SSE Composite Index | 3,735.37 | 4.45 | 0.12% |